Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Krailo

Showing results (61-70 of 161) with videos related to

Pageof 17
Sort By:
Pediatric Blood & Cancer|May 26, 2017
The prognostic significance of circulating serum amyloid A and CXC chemokine ligand 4 in osteosarcomaRicardo J Flores, Aaron J Kelly, Yiting Li, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 15, 2011
Early and late extensive chronic graft-versus-host disease in children is characterized by different Th1/Th2 cytokine profiles: findings of the Children's Oncology Group Study ASCT0031Jacob Rozmus, Kirk R Schultz, Kristin Wynne, et al.
Pediatric Blood & Cancer|December 21, 2012
Children's Oncology Group's 2013 blueprint for research: rare tumorsCarlos Rodriguez-Galindo, Mark Krailo, Lindsay Frazier, et al.
Pediatric Blood & Cancer|June 30, 2012
Phase 2 trial of pemetrexed in children and adolescents with refractory solid tumors: a Children's Oncology Group studyAnne B Warwick, Suman Malempati, Mark Krailo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2005
A phase I and pharmacokinetic study of ecteinascidin-743 (Yondelis) in children with refractory solid tumors. A Children's Oncology Group studyLoretta Lau, Jeffery G Supko, Susan Blaney, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 27, 2007
Altered Toll-like receptor 9 responses in circulating B cells at the onset of extensive chronic graft-versus-host diseaseKevin She, Andrew L Gilman, Soudabeh Aslanian, et al.
Pediatric Blood & Cancer|November 2, 2013
Analysis of serum insulin growth factor-1 concentrations in localized osteosarcoma: a children's oncology group studyScott C Borinstein, Donald A Barkauskas, Mark Bernstein, et al.
American Journal of Medical Genetics. Part A|June 18, 2014
Congenital abnormalities and hepatoblastoma: a report from the Children's Oncology Group (COG) and the Utah Population Database (UPDB)Rajkumar Venkatramani, Logan G Spector, Michael Georgieff, et al.
Methods in Molecular Biology (Clifton, N.J.)|August 28, 2020
Developing and Using a Data Commons for Understanding the Molecular Characteristics of Germ Cell TumorsBo Ci, Shin-Yi Lin, Bo Yao, et al.
Pediatric Blood & Cancer|January 21, 2006
Analysis of biologic surrogate markers from a Children's Oncology Group Phase I trial of gefitinib in pediatric patients with solid tumorsAntonio Jimeno, Najat C Daw, Maria L Amador, et al.
Pageof 17

Showing results (61-70 of 161) with videos related to

Sort By:
Pageof 17
Pediatric Blood & Cancer|May 26, 2017
The prognostic significance of circulating serum amyloid A and CXC chemokine ligand 4 in osteosarcomaRicardo J Flores, Aaron J Kelly, Yiting Li, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 15, 2011
Early and late extensive chronic graft-versus-host disease in children is characterized by different Th1/Th2 cytokine profiles: findings of the Children's Oncology Group Study ASCT0031Jacob Rozmus, Kirk R Schultz, Kristin Wynne, et al.
Pediatric Blood & Cancer|December 21, 2012
Children's Oncology Group's 2013 blueprint for research: rare tumorsCarlos Rodriguez-Galindo, Mark Krailo, Lindsay Frazier, et al.
Pediatric Blood & Cancer|June 30, 2012
Phase 2 trial of pemetrexed in children and adolescents with refractory solid tumors: a Children's Oncology Group studyAnne B Warwick, Suman Malempati, Mark Krailo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2005
A phase I and pharmacokinetic study of ecteinascidin-743 (Yondelis) in children with refractory solid tumors. A Children's Oncology Group studyLoretta Lau, Jeffery G Supko, Susan Blaney, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 27, 2007
Altered Toll-like receptor 9 responses in circulating B cells at the onset of extensive chronic graft-versus-host diseaseKevin She, Andrew L Gilman, Soudabeh Aslanian, et al.
Pediatric Blood & Cancer|November 2, 2013
Analysis of serum insulin growth factor-1 concentrations in localized osteosarcoma: a children's oncology group studyScott C Borinstein, Donald A Barkauskas, Mark Bernstein, et al.
American Journal of Medical Genetics. Part A|June 18, 2014
Congenital abnormalities and hepatoblastoma: a report from the Children's Oncology Group (COG) and the Utah Population Database (UPDB)Rajkumar Venkatramani, Logan G Spector, Michael Georgieff, et al.
Methods in Molecular Biology (Clifton, N.J.)|August 28, 2020
Developing and Using a Data Commons for Understanding the Molecular Characteristics of Germ Cell TumorsBo Ci, Shin-Yi Lin, Bo Yao, et al.
Pediatric Blood & Cancer|January 21, 2006
Analysis of biologic surrogate markers from a Children's Oncology Group Phase I trial of gefitinib in pediatric patients with solid tumorsAntonio Jimeno, Najat C Daw, Maria L Amador, et al.
Pageof 17